UBS raised the firm’s price target on Corteva (CTVA) to $71 from $67 and keeps a Buy rating on the shares post the earnings report.
UBS raised the firm’s price target on Corteva (CTVA) to $71 from $67 and keeps a Buy rating on the shares post the earnings report.